GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » A Plus Biotechnology Co Ltd (ROCO:6918) » Definitions » Notes Receivable

A Plus Biotechnology Co (ROCO:6918) Notes Receivable : NT$0.0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is A Plus Biotechnology Co Notes Receivable?

A Plus Biotechnology Co's Notes Receivable for the quarter that ended in Dec. 2024 was NT$0.0 Mil.


A Plus Biotechnology Co Notes Receivable Historical Data

The historical data trend for A Plus Biotechnology Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

A Plus Biotechnology Co Notes Receivable Chart

A Plus Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial - - - - -

A Plus Biotechnology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

A Plus Biotechnology Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


A Plus Biotechnology Co Notes Receivable Related Terms

Thank you for viewing the detailed overview of A Plus Biotechnology Co's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


A Plus Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 21, Qiaohe Road, 3rd Floor, Zhonghe District, New Taipei City, TWN
A Plus Biotechnology Co Ltd provides orthopedic implants. It engages in the research and development of orthopedic medical products. Aplus locking plate systems feature superior anatomical bone curves and 5-axis CNC manufacturing technology.

A Plus Biotechnology Co Headlines

No Headlines